Signaling conjugates and methods of use

Patent metadata

Field	Value
Publication number	US-10041950-B2
Application number	US-201313849160-A
Country	US
Kind code	B2
Filing date	Mar 22, 2013
Priority date	Mar 27, 2012
Publication date	Aug 7, 2018
Grant date	Aug 7, 2018

Abstract

Disclosed herein are embodiments of a signaling conjugate, embodiments of a method of using the signaling conjugates, and embodiments of a kit comprising the signaling conjugate. The disclosed signaling conjugate comprises a latent reactive moiety and a chromogenic moiety that may further comprise a linker suitable for coupling the latent reactive moiety to the chromogenic moiety. The signaling conjugate may be used to detect one or more targets in a biological sample and are capable of being covalently deposited directly on or proximally to the target. Particular disclosed embodiments of the method of using the signaling conjugate comprise multiplexing methods.

First claim

We claim:

1. A method, comprising:
(a) contacting a biological sample comprising a first target with a first detection probe which binds to the first target, wherein said biological sample is immobilized on a solid support;
(b) after step (a), contacting the solid support comprising the biological sample with a first enzyme conjugate comprising a first enzyme, wherein the first enzyme conjugate binds to the first detection probe and forms a first binding complex comprising the first target, the first detection probe and first enzyme conjugate;
(c) after step (b), contacting the solid support comprising the biological sample with a first signaling conjugate comprising a first phenolic moiety and a first chromogenic moiety, such that the first signaling conjugate contacts the first enzyme conjugate, the first enzyme conjugate catalyzes conversion of the first phenolic moiety into a first reactive species which covalently binds to (i) a location on the first binding complex proximate to or directly on the first enzyme conjugate of the first binding complex; or (ii) a location on the first binding complex proximal to or directly on the first target of the first binding complex; and a second binding complex comprising the first target, the first detection probe, the first enzyme conjugate and the first reactive species is formed, wherein the first reactive species comprises the first chromogenic moiety;
(d) after step (c), removing the first chromogenic moiety unbound to the first binding complex by washing the solid support, thereby producing a stained biological sample comprising the second binding complex on the solid support; and
(e) exposing the first chromogenic moiety of the second binding complex of the stained biological sample on the solid support to light, wherein the first chromogenic moiety produces a colored signal when it is exposed to said light, and detecting the first target by analyzing the stained biological sample using bright-field microscopy,
wherein the first enzyme is a peroxidase; steps (a)-(d) are performed on an automated slide staining instrument; the first target comprises a polypeptide or a nucleic acid; and the biological sample is derived from a human.

2. The method according to claim 1 , wherein the first detection probe comprises an oligonucleotide fragment, hapten, and/or an antibody.

3. The method according to claim 1 , wherein the first enzyme conjugate comprises an antibody conjugated to said first enzyme.

4. The method according to claim 3 , wherein the antibody is an anti-species or an anti-hapten antibody.

5. The method according to claim 1 , wherein the first target comprises a polypeptide and the first reactive species reacts with a tyrosine residue of said polypeptide.

6. The method according to claim 2 , wherein the first detection probe comprises a hapten selected from an oxazole hapten, pyrazole hapten, thiazole hapten, nitroaryl hapten, benzofuran hapten, triterpene hapten, urea hapten, thiourea hapten, rotenoid hapten, coumarin hapten, cyclolignan hapten, di-nitrophenyl hapten, biotin hapten, digoxigenin hapten, fluorescein hapten, or rhodamine hapten.

7. The method according to claim 1 , wherein said first chromogenic moiety of the second binding complex of said stained biological sample absorbs at least about 5% of incident light from said bright-field microscopy.

8. The method according to claim 7 , wherein the first chromogenic moiety has a spectral absorbance when it exposes to the incident light.

9. The method according to claim 8 , wherein said spectral absorbance has a full-width at half-max (FWHM) between about 10 nm and about 150 nm.

10. The method according to claim 1 , wherein said light is generated from a spectrally narrow light source having a spectral emission with a full-width at half-max (FWHM) between about 30 nm and about 150 nm.

11. The method according to claim 10 , wherein said light is generated from an LED light source.

12. The method according to claim 10 , wherein said light is generated from a filtered light source.

13. The method according to claim 1 , further comprising adding a peroxide to step (c).

14. The method according to claim 1 , further comprising: contacting the biological sample with a tyrosine-containing reagent and a cross-linking reagent that binds the tyrosine-containing reagent to the biological sample, wherein the tyrosine-containing reagent provides additional covalent binding sites for the first reactive species.

15. The method according to claim 1 , wherein the signaling conjugate comprises a tyramide or tyramide derivative.

16. A method, comprising:
(a) contacting a biological sample immobilized on a solid support with a first detection probe which binds to a first target;
(b) after step (a), contacting the solid support comprising the biological sample with a first enzyme conjugate comprising a first enzyme, wherein the first enzyme conjugate binds to the first detection probe and forms a first binding complex comprising the first target, the first detection probe and the first enzyme conjugate;
(c) after step (b), contacting the solid support comprising the biological sample with a first signaling conjugate comprising a first phenolic moiety and a first chromogenic moiety, such that the first signaling conjugate contacts the first enzyme conjugate, the first enzyme conjugate catalyzes conversion of the first phenolic moiety into a first reactive species which covalently binds to (i) a location on the first binding complex proximate to or directly on the first enzyme conjugate of the first binding complex; or (ii) a location on the first binding complex proximal to or directly on the first target of the first binding complex; and a second binding complex comprising the first target, the first detection probe, the first enzyme conjugate and the first reactive species is formed, wherein the first reactive species comprises the first chromogenic moiety;
(d) after step (c), removing the first chromogenic moiety unbound to the first binding complex by washing the solid support, thereby producing a stained biological sample comprising the second binding complex on the solid support; and
(e) exposing the first chromogenic moiety of the second binding complex of the stained biological sample on the solid support to light, wherein the first chromogenic moiety produces a colored signal when it is exposed to said light, and detecting the first target by analyzing the stained biological sample using bright-field microscopy,
wherein the first enzyme is a peroxidase; steps (a)-(d) are performed on an automated slide staining instrument; the first target comprises a polypeptide or a nucleic acid; and the biological sample is derived from a human.

17. The method according to claim 16 , wherein the signaling conjugate comprises a tyramide or tyramide derivative.

18. A method, comprising:
(a) contacting a biological sample immobilized on a solid support with a first detection probe which binds to a first target;
(b) after step (a), contacting the solid support comprising the biological sample with a first enzyme conjugate comprising a first enzyme, wherein the first enzyme conjugate binds to the first detection probe and forms a first binding complex comprising the first target, the first detection probe and the first enzyme conjugate;
(c) after step (b), contacting the solid support comprising the biological sample with a first signaling conjugate comprising a first phenolic moiety, a linker selected to improve hydrophilic solution solubility of the first signaling conjugate,

Assignees

• Ventana Med Syst Inc

Inventors

• Alexander Nelson
• Day William
• Kosmeder Ii Jerome W
• Lefever Mark
• Morrison Larry
• Pedata Anne M
• Stanislaw Stacey

Classifications

• G01N33/53

  Immunoassay; Biospecific binding assay; Materials therefor · CPC title

• C12Q1/68

  involving nucleic acids · CPC title

• G01N33/581 Primary

  with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates) · CPC title

• G01N33/542

  with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title

• C12Q1/682

  Signal amplification · CPC title